CIDeRplusGeneral Information:
| Id: | 11,776 (click here to show other Interactions for entry) |
| Diseases: |
Cardiovascular disease
Diabetes mellitus, type II - [OMIM] Insulin resistance |
| Mammalia | |
| review | |
| Reference: | Bader M(2013) ACE2, angiotensin-(1-7), and Mas: the other side of the coin Pflugers Arch. 465: 79-85 [PMID: 23463883] |
Interaction Information:
| Comment | Angiotensin peptides are metabolized by several subsequent enzymatic steps: First, renin cleaves angiotensinogen, into angiotensin I (Ang I). Ang I can be metabolized by angiotensin-converting enzyme (ACE) resulting in the production of the bioactive octapeptide angiotensin II (Ang II), which interacts with AT1 and AT2 receptors. Alternatively, it can be processed first by ACE2 to the inactive peptide Ang-(1‚Äď9) and then by ACE to Ang-(1‚Äď7) or by neutral endopeptidase 24.11 (NEP) or prolylendopeptidase (PEP) directly to Ang-(1‚Äď7). Ang-(1‚Äď7) can also be generated by ACE2 from Ang II and interacts with its receptor Mas. |
|
Formal Description Interaction-ID: 116588 |
|
| Drugbank entries | Show/Hide entries for ACE2 |